Literature DB >> 2222539

Intravenous pulse cyclophosphamide therapy in myositis and Sjögren's syndrome.

J P Leroy1, A A Drosos, D I Yiannopoulos, P Youinou, H M Moutsopoulos.   

Abstract

We describe a patient with primary Sjögren's syndrome who developed myositis. The results of muscle pathologic analysis before and after treatment with monthly pulses of cyclophosphamide (intravenously), are presented.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2222539     DOI： 10.1002/art.1780331017

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


  5 in total

Review 1.  Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome.

Authors:  P Oxholm; J U Prause; M Schiødt
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546

Review 2.  Treatment of oral dryness related complaints (xerostomia) in Sjögren's syndrome.

Authors:  W A van der Reijden; A Vissink; E C Veerman; A V Amerongen
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

3.  Successful treatment of refractory polymyositis with the immunosuppressant mizoribine: case report.

Authors:  A Suwa; M Hirakata; Y Kaneko; S Sato; Y Suzuki; M Kuwana
Journal:  Clin Rheumatol       Date:  2008-12-09       Impact factor: 2.980

4.  A Case of Sjögren's Syndrome Mimicking Inflammatory Myopathy.

Authors:  Shaweta Khosa; Dominic A Hovsepian; Gurveer S Khosa; Yim Catherine; Bhavesh Trikamji; Shri K Mishra
Journal:  Cureus       Date:  2018-10-01

5.  Sjögren Syndrome Associated with Inflammatory Muscle Diseases.

Authors:  Michail P Migkos; Ioannis Sarmas; George A Somarakis; Paraskevi V Voulgari; Konstantinos I Tsamis; Alexandros A Drosos
Journal:  Mediterr J Rheumatol       Date:  2018-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.